Science
Mechanism of Action
This peptide operates by mimicking the N-terminal end of the SNAP-25 protein, which consequently interferes with the proper assembly of the SNARE complex. This interference destabilizes the complex, leading to an inhibition in the release of neurotransmitters, specifically acetylcholine, that initiate muscle contractions. By reducing these contractions, HEXAPEPTIDE-8 effectively lessens the visibility of dynamic wrinkles and expression lines. Furthermore, it is suggested to support collagen synthesis for improved skin elasticity and may indirectly influence sebaceous gland activity, potentially limiting sebum production, erythema, and acne lesion formation through reduced acetylcholine availability.
Research
Clinical Evidence
High confidence0.2%
Key findings
- 01 Demonstrated significant improvements in both wrinkle depth and number after four weeks when applied twice daily within an emulsion. This concentration range (0.05–0.2%) is recommended for maximal efficacy.
- 02 Achieved a 17% reduction in wrinkle depth specifically around the eyes after 15 days of consistent use.
- 03 Resulted in a 16.26% decrease in wrinkle depth after 28 days of use. This study also noted an increase in skin moisturization and significant reductions in both wrinkle depth and width.
- 04 Reduced the depth of wrinkles by 30% after 30 days in vivo when incorporated into a face cream formulation.
Transparency
Dusting Analysis
The Cosmetic Ingredient Review (CIR) Expert Panel concluded that Acetyl Hexapeptide-8 is safe for cosmetic use at concentrations up to 0.005%. However, numerous clinical studies demonstrating significant anti-wrinkle efficacy utilize concentrations substantially higher, ranging from 0.05% to 10%. This creates a critical discrepancy where concentrations required for observable benefits far exceed the CIR's established safety threshold, indicating that products formulated for robust efficacy may operate outside of fully evaluated safety parameters.
The Formula
Formulation
Stability
HEXAPEPTIDE-8 is hydrophilic and possesses a relatively large molecular size, which presents inherent challenges for effective dermal delivery across the lipophilic stratum corneum. Its permeability through the skin is significantly enhanced in acidic environments (e.g., pH 2.7) compared to alkaline conditions (e.g., pH 7.4), suggesting improved solubility and potential delivery at lower pH values. Formulation strategies such as oil-in-water (O/W) and multiple water-in-oil-in-water (W/O/W) emulsions have been explored to optimize its skin penetration.
Safety
Safety Profile
The CIR Expert Panel concluded Acetyl Hexapeptide-8 Amide (synonymous with Acetyl Hexapeptide-8) is safe in cosmetics at concentrations up to 0.005%. Data were deemed insufficient for evaluating safety at higher concentrations. The ingredient is not listed on the European Union's restricted or prohibited substances list. The U.S. FDA does not recognize 'cosmeceuticals' and has not approved Acetyl Hexapeptide-8 for drug use as an anti-wrinkle active.
Your Skin
Skin Compatibility
Our Assessment
Verdict
HEXAPEPTIDE-8 is a valuable peptide for effectively mitigating dynamic wrinkles and expression lines through its neurotransmitter-modulating mechanism, supported by strong clinical evidence of efficacy at specific concentrations; however, formulators must critically consider the significant disparity between concentrations proven effective and the Cosmetic Ingredient Review's (CIR) established safety limit of 0.005%, as higher concentrations lack comprehensive safety data evaluation by the CIR.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources